Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
Robert Chiesa(Great Ormond Street Hospital), Paul J. Orchard(University of Minnesota), Vinod K. Prasad(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Mattia Algeri(Bambino Gesù Children's Hospital), Nancy Bunin(Children's Hospital of Philadelphia), Alison Timm(Bluebird Bio (United States)), Jörn‐Sven Kühl(Charité - Universitätsmedizin Berlin), Caroline A. Lindemans(University Medical Center Utrecht), Caroline Sevin(Bicêtre Hospital), Simon Jones(Manchester University NHS Foundation Trust), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Esther Shamir(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Neena Kapoor(University of Southern California), Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Elizabeth McNeil(Bluebird Bio (United States)), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jaap Jan Boelens(Wilhelmina Children's Hospital), Hernán Amartino(Manchester Royal Eye Hospital), Daniel J. Loes(Inserm)
Cited by 40
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592